This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Evaluation of Ocular Comfort With ISTA Tears vs Systane

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01650584
First received: July 24, 2012
Last updated: May 8, 2017
Last verified: May 2017
July 24, 2012
May 8, 2017
June 2012
December 2012   (Final data collection date for primary outcome measure)
Ocular Comfort [ Time Frame: 30 days ]
Same as current
Complete list of historical versions of study NCT01650584 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Evaluation of Ocular Comfort With ISTA Tears vs Systane
To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Dry Eye Disease
  • Drug: ISTA Tears
    sterile ophthalmic solution
  • Drug: Systane
    Sterile ophthalmic solution
  • Experimental: ISTA Tears
    Sterile ophthalmic solution
    Intervention: Drug: ISTA Tears
  • Active Comparator: Systane
    Sterile ophthalmic solution
    Intervention: Drug: Systane
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
35
January 2013
December 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • OSDI >12

Exclusion Criteria:

  • Presence of any active ocular disease other than dry eye
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01650584
S00231
No
Not Provided
Not Provided
Bausch & Lomb Incorporated
Bausch & Lomb Incorporated
Not Provided
Study Director: Tim McNamara, PharmD ISTA Pharmaceuticals, Inc.
Bausch & Lomb Incorporated
May 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP